National Institutes of Health: all 11,571 studies

Page 37 of 116. Open to participants first (946), then studies with results posted, then the rest; newest registration first within each.

• Anti-Inflammatory Effects of Time-Restricted FeedingCompletedNCT04728165
• Microbiome as a ThErapeutic Response BiomarkerWithdrawnNCT04721743
• A Phase I/II Study of Combination Immunotherapy for Advanced Cancers Including HPV-Associated Malignancies, Small Bowel, and Colon CancersCompletedNCT04708470Phase 1/2
• A Study Evaluating Whether Pembrolizumab Alone or in Combination With CMP-001 Improves Efficacy of Treatment in Patients With Operable MelanomaActive, not recruitingNCT04708418Phase 2
• Community Dynamics of Malaria Transmission in Humans and Mosquitoes in Fleh-la and Marshansue, Salala District, Bong County, LiberiaActive, not recruitingNCT04704674
• Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH TrialActive, not recruitingNCT04704661Phase 1
• Impact of COVID-19 on the Incidence, Characteristics, Management and Outcome of SepsisWithdrawnNCT04698382
• Biomarkers in Ocular Inflammation and UveitisCompletedNCT04690829
• Natural History of Coronavirus Disease (COVID-19) in Systemic Autoimmune DiseasesCompletedNCT04690816
• FES Assisted Cycling in Children With CPCompletedNCT04688424Not applicable
• Hospital COVID-19 Surge and Associated Mortality RiskCompletedNCT04688372
• Mental Health Impact of the COVID-19 Pandemic on Amish and Mennonite Participants in AMBiGenCompletedNCT04684615
• Utility of Empiric Antibiotics for Non-intubated Novel Coronavirus Diseases 2019 PatientsWithdrawnNCT04674410
• Review of Post-Study Clinical Endoscopy Reports in Follow Up to MAY2016-07-01TerminatedNCT04674228
• Assessing Sleep and Circadian Rhythms in Primary Brain Tumors PatientsCompletedNCT04669574
• Ocular Findings and Viral Persistence in Ocular Fluids in COVID-19 SurvivorsTerminatedNCT04665752
• Gene First Approach to Connective Tissue DiseaseCompletedNCT04664478
• Evaluation of Atherosclerotic Plaques in Abdominal CT StudiesActive, not recruitingNCT04652973
• Duvelisib and Nivolumab for the Treatment of Stage IIB-IVB Mycosis Fungoides and Sezary SyndromeActive, not recruitingNCT04652960Phase 1
• Malaria Transmission in Humans and Mosquitoes at the Area of Sabou, Burkina FasoCompletedNCT04650815
• Aerosolized Azacytidine as Epigenetic Priming for Bintrafusp Alfa-Mediated Immune Checkpoint Blockade in Patients With Unresectable Pulmonary Metastases From Sarcomas, Germ Cell Tumors, or Epithelial MalignanciesWithdrawnNCT04648826Phase 1/2
• Doxorubicin, CC-(486) (5-azacitidine), Romidepsin, and Duvelisib (hARD) for T-cell LymphomaWithdrawnNCT04639843Phase 1
• Electrophysiologic Sleep Phenotyping and Sleep-Dependent Neuro-maturation in Clinical and Healthy Pediatric PopulationsActive, not recruitingNCT04639830
• Trimethoprim-Sulfamethoxazole vs Levofloxacin as Targeted Therapy for Stenotrophomonas Maltophilia Infections: a Retrospective Cohort StudyCompletedNCT04639817
• Collection of Clinical Data and Specimens for Research on Head and Neck and Communication DisordersTerminatedNCT04618432
• Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Long-term Mitapivat Dosing in Subjects With Stable Sickle Cell Disease: An Extension of a Phase I Pilot Study of MitapivatActive, not recruitingNCT04610866Phase 1/2
• SARS-COV2 Pandemic Serosurvey in a Rare Disease PopulationCompletedNCT04609085
• Testing the Addition of Lenalidomide and Nivolumab to the Usual Treatment for Primary CNS LymphomaActive, not recruitingNCT04609046Phase 1
• Patients' Long-Term Survival of Obstructive Hypertrophic Cardiomyopathy (HCM)CompletedNCT04603521
• Factors Influencing Fertility or Pregnancy HealthActive, not recruitingNCT04595760
• Testing the Anti-cancer Drug, Rogaratinib (BAY 1163877), for Treatment of Advanced Sarcoma With Alteration in Fibroblast Growth Factor Receptor (FGFR 1-4), and in Patients With SDH-deficient Gastrointestinal Stromal Tumor (GIST)Active, not recruitingNCT04595747Phase 2
• Defining the COVID-19 Immunity Denominator in the Mekong: a Cross-Sectional Seroprevalence Study of SARS-CoV-2 in HealthyVolunteersWithdrawnNCT04594395
• COVID-19: Pediatric Research Immune Network on SARS-CoV-2 and MIS-CCompletedNCT04588363
• Development and Evaluation of Techniques for Computer Aided Detection and Diagnosis From Existing Radiologic ImagesActive, not recruitingNCT04579237
• Comparing the New Anti-cancer Drug Eribulin With Chemotherapy Against the Usual Chemotherapy Alone in Metastatic Urothelial CancerActive, not recruitingNCT04579224Phase 3
• Pomalidomide Treatment in Patients With Kaposi SarcomaActive, not recruitingNCT04577755Phase 2
• A Study to Compare Treatment With the Drug Selumetinib Alone Versus Selumetinib and Vinblastine in Patients With Recurrent or Progressive Low-Grade GliomaActive, not recruitingNCT04576117Phase 3
• Clinical Correlates of COVID-19 Pandemic in Patients With Functional Movement Disorder (FMD) and Parkinson's Disease (PD)CompletedNCT04565080
• Identification and Characterization of SARS-CoV-2 Specific CD8 T Cells in HumansActive, not recruitingNCT04565067
• An Observational Study of Neurologic Function After COVID-19 InfectionCompletedNCT04564287
• COV2Base-A Rare Disease by COVID StudyCompletedNCT04564274
• Chronic Prostatitis Collaborative Research Network Clinical Trial- Ciprofloxacin and TamsulosinCompletedNCT04552431Phase 2
• Measuring the Effects of Talazoparib in Patients With Advanced Cancer and DNA Repair VariationsActive, not recruitingNCT04550494Phase 2
• Testing the Addition of Pembrolizumab, an Immunotherapy Cancer Drug to Olaparib Alone as Therapy for Patients With Pancreatic Cancer That Has Spread With Inherited BRCA MutationsActive, not recruitingNCT04548752Phase 2
• Oral Metformin for Treatment of ABCA4 RetinopathyActive, not recruitingNCT04545736Phase 1/2
• Integrated Genomic Prostate Score With MRI Targeted Prostate BiopsiesActive, not recruitingNCT04541030
• Testing a New Immune Cell Therapy, GD2-Targeted Modified T-cells (GD2CART), in Children, Adolescents, and Young Adults With Relapsed/Refractory Osteosarcoma and Neuroblastoma, GD2-CAR PERSIST TrialSuspendedNCT04539366Phase 1
• Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Mutated or Viral Neoantigens in a Patient With Metastatic Cancer Plus the Administration of PembrolizumabWithdrawnNCT04536922Phase 2
• Testing the Addition of M3814 (Peposertib) to Radiation Therapy for Patients With Advanced Head and Neck Cancer Who Cannot Take CisplatinActive, not recruitingNCT04533750Phase 1
• Effect of Atazanavir-ritonavir on the Pharmacokinetics and Toxicity of LumefantrineCompletedNCT04531072Phase 4
• Testing the Use of Steroids and Tyrosine Kinase Inhibitors With Blinatumomab or Chemotherapy for Newly Diagnosed BCR-ABL-Positive Acute Lymphoblastic Leukemia in AdultsActive, not recruitingNCT04530565Phase 3
• The Influence of Malnutrition, Diabetes Mellitus, and Helminth Infections on Biosignatures in Latent Tuberculosis in a South Indian PopulationCompletedNCT04526613
• A Cluster-randomized Trial to EValuate the Efficacy of Wolbachia-InfecTed Aedes Aegypti Mosquitoes in Reducing the Incidence of Arboviral Infection in Brazil (EVITA Dengue)CompletedNCT04514107Not applicable
• ACTIV-3: Therapeutics for Inpatients With COVID-19CompletedNCT04501978Phase 3
• Testing the Combination of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) in Children, Adolescent, and Young Adult Patients With Relapsed/Refractory Cancers That Have an Increased Number of Genetic Changes, The 3CI StudyWithdrawnNCT04500548Phase 1
• Testing the Response to the Anti-cancer Drug, Triapine, in Uterine Cancers Using Markers From the Tissue at the Time of HysterectomyActive, not recruitingNCT04494113Early Phase 1
• Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial CancerActive, not recruitingNCT04491942Phase 1
• Serological Surveillance for COVID-19 in Central North CarolinaCompletedNCT04490174
• Natural History Study of Children and Adults With Neuroendocrine Neoplasms (NEN)sTerminatedNCT04488263
• Mobile Sensor Technologies to Assess General Symptomology of People With CancerCompletedNCT04465214
• Retrospective Case Series of Trans-scleral Cryotherapy for Retinal HemangioblastomaCompletedNCT04458935
• Natural History Study of Children and Adults With Adrenocortical Cancer (ACC)TerminatedNCT04447014
• EA2176: Phase 3 Clinical Trial of Carboplatin and Paclitaxel +/- Nivolumab in Metastatic Anal Cancer PatientsActive, not recruitingNCT04444921Phase 3
• Machine Learning to Analyze Facial Imaging, Voice and Spoken Language for the Capture and Classification of Cancer/Tumor PainCompletedNCT04442425
• Testing Dasatinib as a Potential Targeted Treatment in Cancers With DDR2 Genetic Changes (MATCH-Subprotocol X)WithdrawnNCT04439305Phase 2
• Retrospective Study of Patients With Severe Aplastic Anemia Who Relapsed After Immunosuppressive TherapyCompletedNCT04436380
• Retrospective Study of Patients With Severe Aplastic Anemia Who Developed High Risk Clonal Evolution With Chromosome 7 Abnormalities After Immunosuppressive TherapyCompletedNCT04436367
• Layer-specific Contribution to Consolidation of Skill Learning in the Primary Motor CortexCompletedNCT04431011
• Attentional Performance in Parkinson DiseaseWithdrawnNCT04428931
• Biospecimen Procurement for Immunological Landscape Studies Following Hematopoietic Cell TransplantationWithdrawnNCT04428918
• Saliva as Source of Detection for SARS-CoV-2CompletedNCT04424446
• Living With Sickle Cell Disease in the COVID-19 PandemicCompletedNCT04417673
• Bintrafusp Alfa (M7824) in Subjects With Thymoma and Thymic CarcinomaActive, not recruitingNCT04417660Phase 2
• A Longitudinal Study of COVID-19 Sequelae and ImmunityActive, not recruitingNCT04411147
• E7 TCR T Cell Immunotherapy for High-Grade Cervical Intraepithelial NeoplasiaWithdrawnNCT04411134Phase 1
• Sample Collection for Systems Evaluation of Patients With Unknown or Incompletely Characterized Immune DefectsCompletedNCT04408950
• Prospective Natural History Study of Smoking, Immune Cell Profiles, Epigenetics and COVID-19CompletedNCT04403386
• Testing the Addition of Radiation Therapy to the Usual Immune Therapy Treatment (Atezolizumab) for Extensive Stage Small Cell Lung Cancer, The RAPTOR TrialSuspendedNCT04402788Phase 2/3
• Cardiopulmonary Inflammation and Multi-System Imaging During the Clinical Course of COVID-19 Infection in Asymptomatic and Symptomatic PersonsCompletedNCT04401449
• COVID-19 Associated Lymphopenia Pathogenesis Study in BloodCompletedNCT04401436
• Pathogenesis of BTK-mediated Hyper-Inflammatory Responses in COVID-19 (RESPOND)WithdrawnNCT04394884
• Testing the Addition of an Anticancer Drug, Olaparib, to the Usual Chemotherapy (Temozolomide) for Advanced Neuroendocrine CancerActive, not recruitingNCT04394858Phase 2
• NCI COVID-19 in Cancer Patients, NCCAPS StudyActive, not recruitingNCT04387656
• Surveillance of Individuals Following SARS-CoV-2 InfectionCompletedNCT04383444
• Immunophenotyping Assessment in a COVID-19 CohortCompletedNCT04378777
• Impact on Anxiety and Motivation of COVID-19 and Predictors of Individual ResponsesCompletedNCT04377100
• Testing the Safety of CB-5339 in Patients With CancerWithdrawnNCT04372641Phase 1
• Genetics of COVID-19 Susceptibility and ManifestationsCompletedNCT04371432
• Matched Related and Unrelated Donor Stem Cell Transplantation for Severe Combined Immune Deficiency (SCID): Busulfan-based Conditioning With h-ATG, Radiation, and SirolimusWithdrawnNCT04370795Phase 1/2
• African American Study of Kidney Disease and HypertensionCompletedNCT04364139Phase 3
• The Modification of Diet in Renal Disease StudyCompletedNCT04364113Phase 3
• Investigation of the B- and T-cell Repertoire and Immune Response in Patients With Acute and Resolved COVID-19 InfectionCompletedNCT04362865
• Plasma Collection From Convalescent and/or Immunized Donors for the Treatment of COVID-19CompletedNCT04360278
• Effect of Acute Alcohol Intoxication on Neural Processes During Decisions to Engage in HIV Risk BehaviorsCompletedNCT04360018Phase 1
• Optimal Methods of Disease Progression and Survival Analysis in Children and Adults Patients With Adrenocortical Cancer (ACC)Active, not recruitingNCT04358107
• Safety and Efficacy Study of Meningococcal Group B Vaccine rMenB+OMV NZ (Bexsero) to Prevent Gonococcal InfectionCompletedNCT04350138Phase 2
• Venous Thrombosis Biomarkers in Sickle Cell Disease and Sickle Cell TraitCompletedNCT04349189
• Transmissibility and Viral Load of SARS-CoV-2 in Oral SecretionsCompletedNCT04348240
• Collection of Anti-SARS-CoV-2 Immune PlasmaCompletedNCT04344977
• Study of Volition: Behavioral Analysis and Clinical Neurophysiological AnalysisCompletedNCT04344470Not applicable

← National Institutes of Health overview and focus areas